Development of new vitamin D analogs.

作者: LISE BINDERUP , ERNST BINDERUP , WAGN O. GODTFREDSEN , ANNE-MARIE KISSMEYER

DOI: 10.1016/B978-012252687-9/50088-7

关键词: Vitamin D and neurologyPharmacologyImmunologyBiologyReceptorImmunological diseasesPsoriasis

摘要:

参考文章(138)
Barker Jn, PSORIASIS AS A T CELL-MEDIATED AUTOIMMUNE DISEASE Hospital Medicine. ,vol. 59, pp. 530- 533 ,(1998)
S. C. Manolagas, Xiao-Peng Yu, F. G. Hustmyer, Immunomodulating properties of 1,25-dihydroxyvitamin D3. Kidney International. ,vol. 38, ,(1990)
Morimoto S, Kumahara Y, A patient with psoriasis cured by 1 alpha-hydroxyvitamin D3. Medical journal of Osaka University. ,vol. 35, pp. 51- 54 ,(1985)
Gunnar Tufveson, Cecilia Johnsson, Lise Binderup, Immunosuppression with the vitamin D analogue MC 1288 in experimental transplantation. Transplantation Proceedings. ,vol. 28, pp. 888- ,(1996)
S. Masuda, S. Strugnell, M.J. Calverley, H.L. Makin, R. Kremer, G. Jones, In vitro metabolism of the anti-psoriatic vitamin D analog, calcipotriol, in two cultured human keratinocyte models. Journal of Biological Chemistry. ,vol. 269, pp. 4794- 4803 ,(1994) , 10.1016/S0021-9258(17)37614-7
John A. Eisman, Robert L. Sutherland, Masafumi Koga, Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells. Cancer Research. ,vol. 48, pp. 2734- 2739 ,(1988)
Phillip P. Minghetti, Anthony W. Norman, 1,25(OH)2-vitamin D3 receptors: gene regulation and genetic circuitry. The FASEB Journal. ,vol. 2, pp. 3043- 3053 ,(1988) , 10.1096/FASEBJ.2.15.2847948